60429-850 : Darifenacin Hydrobromide Extended-release 7.5 mg Oral Tablet, Extended Release


NDC: 60429-850
Labeler: Golden State Medical Supply, Inc.
Product Type: Human Prescription Drug
Drug Name:  Darifenacin Hydrobromide Extended-release
Dosage Form: Oral Tablet, Extended Release
Application #: ANDA091190
Rev. Date: 


Appearance:


Markings: C170
Shapes:  Round
Colors:  Yellow
Size (mm): 8
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 60429-850-30: 30 TABLET, EXTENDED RELEASE IN 1 BOTTLE (60429‑850‑30)

Active Ingredients:

  • Darifenacin Hydrobromide

Dosage Strength:

  • 7.5 mg

Inactive Ingredients:

  • Anhydrous Dibasic Calcium Phosphate
  • Hypromellose 2208 (3 Mpa.s)
  • Lactose Monohydrate
  • Magnesium Stearate
  • Polyvinyl Alcohol, Unspecified
  • Talc
  • Polyethylene Glycol, Unspecified
  • Titanium Dioxide
  • D&c Yellow No. 10
  • Fd&c Yellow No. 6

Pharmaceutical Classes:

  • Cholinergic Muscarinic Antagonist [EPC]
  • Cholinergic Muscarinic Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 60429-851 Darifenacin Hydrobromide Extended-release 15 mg Oral Tablet, Extended Release by Golden State Medical Supply, Inc.
  • 10370-170 Darifenacin Hydrobromide Extended-release 7.5 mg Oral Tablet, Extended Release by Par Pharmaceutical
  • 10370-171 Darifenacin Hydrobromide Extended-release 15 mg Oral Tablet, Extended Release by Par Pharmaceutical
  • 42291-206 Darifenacin Hydrobromide Extended-release 7.5 mg Oral Tablet, Extended Release by Avkare, Inc.
  • 42291-207 Darifenacin Hydrobromide Extended-release 15 mg Oral Tablet, Extended Release by Avkare, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 60429-850 QR Code

< Prev: 60429-849Next: 60429-851 >

Related Discussions:

drug darifenacin
is the drug derifenacin useful in chronic cystitis...
Enablex-darifenacin
Prostate Condition...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.